|
 
 
 
 
 
 
|
I have worked for 20 years in bioethics,
founded the journal Ethics and Medicine in 1983, and am currently
involved in bioethics projects in both Europe and the United States.
It is a privilege to be invited to testify today.
Two great questions confront the human race at
the start of the biotech century. The second, presently only on
the horizons of our thinking and yet of incalculable import, will
focus our growing capacity to design, determine, and transform ourselves
and our nature; the incremental progression toward the so-called
"post-human" future. The first question is the one that
confronts us today: whether we should use members of our own kind,
Homo sapiens sapiens, in whatever stage of biological existence,
for a purpose that is other than the good of the individual concerned;
whether we should sanction the use of ourselves, in however early
a form, as experimental subjects whose final end is destruction.
Let me offer four observations on our dilemma.
First, it seemed until recently to be widely agreed that human embryos
should never be manufactured simply in order to be destroyed through
experiment, however worthy the experiment. This principle is, for
example, enshrined in the European Convention on Human Rights and
Biomedicine, the one international bioethics treaty; and was memorably
captured some years ago in a Washington Post editorial in the ringing
phrase: "The creation of human embryos specifically for research
that will destroy them is unconscionable." Yet the Jones Institute
has brazenly announced that they have done just that. And as Charles
Krauthammers recent pro-stem-cell research piece notes, the
cloning debate has focused the same issue. The chorus of support
for Greenwood-Deutsch has been fed precisely by a scientific-industrial
community eager to clone and destroy embryos for scientific-industrial
purposes.
The problem, of course, is one of drawing lines;
it is the challenge of consistency. May a line truly be drawn that
will permit experimentation on clinically "spare" embryos,
a line that will stand forever and in the face, we may expect, of
mounting commercial and clinical opportunity that argues for their
creation to order? That is of course the compromise that has been
floated in various quarters, most notably and seriously by Senator
Frist. The level of support for embryo cloning-to-order in Greenwood-Deutsch,
and now the timely "ocular proof of the Jones Institute,
suggests the naivete of such policy hopes, since in the minds of
most of those who lead the call for "spare" embryo research
there is only a modest distinction between this politic option and
the Jones way. It is a distinction that falls far, far short of
what the Post designated "unconscionable." It is not,
as we might put it, that we believe that further dominoes will fall;
they are falling all around us. For the logic of the experimental
abuse of "spare" human embryos depends ultimately on so
meager a valuation of the embryo itself that their creation-to-order
is inevitable. If the embryo is at base object and not in any sense
subject, what is to prevent it? It is reported that one celebrity
recently announced here on the Hill and in defense of embryonic
stem-cell research that the embryo is of similar moral standing
to a goldfish.
Secondly, I do not propose to get drawn into the extensive debate
surrounding the relative merits of embryonic and other, typically
adult, stem-cells. Plainly some and perhaps all of the good things
that are prophesied to be the fruit of embryonic stem-cells may
be attained using adult cells or other means. It is ironic, and
to be regretted, that this debate has sometimes seemed to hinge
on whether adult stem-cell work is likely to be as fruitful as the
embryonic kind, as if the moral question, while of some weight,
could be discounted by a certain evaluation of likely relative clinical
outcomes. This is a profound moral debate about what we will and
will not do to our own kind, for whatever alleged benefit.
Thirdly, I believe that we are losing sight of the middle ground.
By that I mean that it is by no means necessary to take the view
that the early embryo is a full human person in order to be convinced
that deleterious experimentation is improper. There are many possible
grounds for such a view that we do not know if the embryo
possesses full human dignity and should therefore be prudent; that
the embryo possesses the potential to be a full human person and
that such inbuilt potentiality entails profound respect, a view
widely held and deeply threatened in this debate; or that membership
in our species is enough to distinguish the human embryo from all
other laboratory artifacts. Indeed, the widely held view that embryos
should not be specially created for experimental purposes itself
reveals a strong if undefined disposition to protect the embryo
from abuse.
Fourthly, let me share my sense of dismay at the degree to which
this debate has sometimes degenerated into an iteration and reiteration
of the potential benefits of this kind of experimentation, as if
those who oppose public funding for what they consider unethical
research are either ignorant of or heedless toward disease and its
sufferers. The celebrity argument is a sham, an attempt to short-circuit
the moral assessment of means by the crass assertion of ends. It
is an embarrassment to the cause of ethics in public policy.
For the question we face is distinctly ethical
in character. At the heart of our conception of civilization lies
the principle of restraint: that there are things we shall not do,
shall never do, even though they may bring us benefit; some things
we shall never do, though the heavens fall.
As we stand on the threshold of the biotech century,
we could hardly confront a decision that is more onerous, since
the promised benefits from this technology may be great. Yet that
is of course simply to focus the moral question. If there are things
that we should not do, it is easy for us to refuse to do them when
they offer no benefit. When the benefit they offer is modest, the
choice is still not hard. The challenge to morals and to public
policy lies precisely here, where the benefits seem great. Yet it
is here also that our intuitive respect for the early embryo requires
us to pay a price. In a culture fixated with the satisfaction of
its needs and the healing of its woes, it has become hard even to
say that we shall never, for whatever benefit, experiment on our
own kind. Shall we do evil, that good may come?
Nigel Cameron is Ethics
and Policy Consultant to CARE and General Editor of CounterCulture
Reprinted with permission
of Prison Fellowship, P.O. Box 17500, Washington, DC, 20041-7500.
www.christianity.com/breakpoint
Return to top
|